JY
BNTX icon

Jeff Yass’s BioNTech BNTX Stock Holding History

Jeff Yass’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Sell
126,616
-66,845
-35% -$6.29M ﹤0.01% 3128
2026
Q1 		$17.2M Buy
193,461
+44,237
+30% +$4.55M ﹤0.01% 2421
2025
Q4 		$14.2M Buy
149,224
+83,564
+127% +$8.42M ﹤0.01% 2600
2025
Q3 		$6.48M Buy
65,660
+51,530
+365% +$5.51M ﹤0.01% 3683
2025
Q2 		$1.5M Buy
14,130
+3,480
+33% +$351K ﹤0.01% 6439
2025
Q1 		$970K Buy
10,650
+2,529
+31% +$283K ﹤0.01% 7333
2024
Q4 		$925K Sell
8,121
-96,888
-92% -$11.1M ﹤0.01% 7154
2024
Q3 		$12.5M Buy
105,009
+98,646
+1,550% +$9.07M ﹤0.01% 2335
2024
Q2 		$511K Sell
6,363
-91,843
-94% -$8.4M ﹤0.01% 8216
2024
Q1 		$9.06M Buy
+98,206
New +$9.42M ﹤0.01% 2740
2023
Q4 		– Sell
-134,807
Closed -$13.6M – 12367
2023
Q3 		$14.6M Buy
134,807
+16,069
+14% +$1.78M ﹤0.01% 2093
2023
Q2 		$12.8M Buy
118,738
+58,483
+97% +$6.58M ﹤0.01% 2206
2023
Q1 		$7.51M Sell
60,255
-35,159
-37% -$4.83M ﹤0.01% 2864
2022
Q4 		$14.3M Buy
95,414
+7,566
+9% +$1.16M ﹤0.01% 1838
2022
Q3 		$11.8M Sell
87,848
-309,657
-78% -$47.3M ﹤0.01% 1948
2022
Q2 		$59.3M Sell
397,505
-62,063
-14% -$9.48M 0.01% 756
2022
Q1 		$78.4M Sell
459,568
-68,215
-13% -$11.5M 0.01% 771
2021
Q4 		$136M Sell
527,783
-399,558
-43% -$109M 0.02% 598
2021
Q3 		$253M Buy
927,341
+236,170
+34% +$75.1M 0.03% 430
2021
Q2 		$155M Buy
691,171
+265,700
+62% +$50.1M 0.02% 612
2021
Q1 		$46.5M Sell
425,471
-195,273
-31% -$20.7M 0.01% 1159
2020
Q4 		$50.6M Buy
620,744
+151,992
+32% +$14.9M 0.01% 999
2020
Q3 		$32.5M Buy
468,752
+328,684
+235% +$23.6M 0.01% 1128
2020
Q2 		$9.35M Buy
+140,068
New +$6.99M ﹤0.01% 2212

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Jeff Yass's BNTX Position: Q2 2026 in Review

Jeff Yass reduced its BioNTech (BNTX) stake by 35% in Q2 2026, selling an estimated $6.29M and leaving 126,616 shares worth $11.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3128.

Jeff Yass first reported a position in BNTX in Q2 2020 and has held it in 24 quarters since. The position peaked at $253M in Q3 2021. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Jeff Yass held 126,616 shares of BioNTech worth $11.8M as of Q2 2026.
  • Jeff Yass sold 66,845 BioNTech shares in Q2 2026, an estimated $6.29M.
  • BioNTech made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #3128 holding.
  • Jeff Yass first reported a position in BioNTech in Q2 2020 and has held it in 24 quarters since.
  • Jeff Yass's BioNTech position peaked at $253M in Q3 2021.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.